Some ingredients are known to cause dizziness
The approval of injectable semaglutide for adolescents aged 12 and older in 2022 established a precedent for GLP-1-based weight management in younger patients, and an oral option could substantially change the treatment calculus for this population
A polypoid mass with tumor cells shows strong, positive staining with S-100 protein immunohistochemical stain (original magnification X2)
I think its a drug that primary care will have an easier time with than a GLP-1 that is more prone to these side effects
The four types of MS each present different challenges for peptide-based interventions
Abd Elrahman MM, El makawy AI, Hassanane MS, Alam SS, Hassan NHA, Amer MK Assessment of correlation between asthenozoospermia and mitochondrial DNA mutations in Egyptian infertile men